Tools & Resources
to Support You

Find Support Today

You can reduce prescription opioid misuse, abuse, and addiction in your practice. We offer a wide variety of tools, resources, and guidelines.

It’s important to focus on the materials that can aid you most with particular patients and their situations. Here, you can gain access to resources in the following key areas: Identification, Management and Education.


Help Identify At-Risk Patients

The first step toward a solution is to identify your patients who may be at risk for misuse, abuse, or addiction.
  • Prescription Drug Monitoring Program (PDMP)
    Prescription Drug Monitoring Program (PDMP)
    Check recent prescribing data for your patients to identify questionable behavior.
    ACCESS YOUR STATE’S PDMP
  • 1-Minute Risk Screener
    1-Minute Risk Screener
    Use this quick opioid risk assessment tool to assess risk for opioid misuse among your patients.
    VIEW PDF
  • Micro-case Series on Opioid Abuse
    Micro-case Series on Opioid Abuse
    This micro-case podcast series details challenges commonly faced by clinicians and delivers clinical pearls in 4 minutes or less.
    LISTEN HERE
  • How Can the PDMP Help?
    How Can the PDMP Help?
    Dr. Daniel P. Alford explains how the PDMP can help identify when a patient obtains multiple prescriptions.

Help Manage Patients

It’s crucial to tailor your approach to each of your identified at-risk patients and build a safe treatment plan.
  • CDC Prescribing Guidelines
    CDC Prescribing Guidelines
    Read the full CDC guidelines for prescribing opioids published in 2016.
    VISIT SITE
  • Search and Rescue Fact Sheet
    Search and Rescue Fact Sheet
    Key tools and resources to help you understand and reduce opioid misuse.
    VIEW PDF
  • Non-Opioid Alternatives for Pain
    Non-Opioid Alternatives for Pain
    Explore new treatments to offer your patients in need of relief.
    VIEW PDF
  • Substance Abuse Treatment Locator
    Substance Abuse Treatment Locator
    Find Treatment for Patients with Substance Use Disorder
    SEARCH NOW
  • Naloxone Recommendations
    Naloxone Recommendations
    To reduce the risk of death from opioid overdose, the U.S. Food and Drug Administration has released new guidance for opioid reversal treatment.
    ACCESS INFORMATION

Expand Your Education

As many patients’ first point of contact, use these materials, including Continuing Medical Education (CME), as a guide to evaluate risks and benefits of opioid treatment.
  • Evaluate Risks and Benefits of Opioid Therapies
    Evaluate Risks and Benefits of Opioid Therapies
    Learn how to address the opioid public health crisis from renowned experts.
    VISIT SITE
  • CME for ER/LA Opioids
    CME for ER/LA Opioids
    Access REMS-compliance CME courses specific to prescribing ER/LA opioid analgesics.
    VISIT SITE
  • REMS (Risk Evaluation and Mitigation Strategy)
    REMS (Risk Evaluation and Mitigation Strategy)
    Review REMS per drug product via the searchable FDA database.
    VIEW DATABASE
  • Help Your Patients Manage Pain Safely and Effectively
    Help Your Patients Manage Pain Safely and Effectively
    Access free Continuing Medical Education (CME) from Boston University to help manage patients with chronic pain who have been prescribed opioid analgesics.
    LEARN MORE

*This campaign is supported by the FDA of the US Department of Health and Human Services (HHS) as part of financial assistance award U18FD004593, with 100% funded by the FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, the FDA/HHS or the US Government.

References
  1. Centers for Disease Control and Prevention. Overdose Death Rates. https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates. Accessed March 21, 2021.
  2. Overdose Detection Mapping Application Program. The consequences of COVID-19 on the overdose epidemic: Overdoses are increasing. https://files.constantcontact.com/a923b952701/dbf0b5a5-f730-4a6f-a786-47097f1eea78.pdf. Accessed March 21, 2021.
  3. American Medical Association. Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic. https://www.ama-assn.org/system/files/2020-12/issue-brief-increases-in-opioid-related-overdose.pdf. Accessed March 21, 2021.
  4. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569-576.
  5. Why guidelines for primary care providers? Centers for Disease Control and Prevention website. https://www.cdc.gov/drugoverdose/pdf/guideline_infographic-a.pdf. Accessed March 21, 2021.
  6. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results From the 2019 National Survey on Drug Use and Health: Detailed Tables. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables. Published September 2020. Accessed March 21, 2021.
  7. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95-100.
  8. Centers for Disease Control and Prevention. Prescription Drug Monitoring Programs (PDMPs). https://www.cdc.gov/drugoverdose/pdmp/providers.html. Accessed April 5, 2021.
  9. Prescription drug monitoring frequently asked questions (FAQ). Brandeis University. Prescription Drug Monitoring Program Training and Technical Assistance Center website. https://www.pdmpassist.org/Policies. Accessed March 21, 2021.
  10. U.S. State Opioid Dispensing Rates, 2019. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. https://www.cdc.gov/drugoverdose/maps/rxstate2019.html. Accessed April 5, 2021.